Leukaemic cells and normal blood-producing cells relate differently to their surroundings. This concept has now been extended to leukaemic stem cells, suggesting a fresh approach to therapy.
References
Jin, L., Hope, K. J., Zhai, Q., Smadja-Joffe, F. & Dick, J. E. Nature Med. 12, 1167–1174 (2006).
Krause, D. S., Lazarides, K., von Andrian, U. H. & Van Etten, R. A. Nature Med. 12, 1175–1180 (2006).
Lord, B. I., Testa, A. G. & Hendry, J. H. Blood 46, 65–72 (1975).
Dexter, T. M. et al. J. Cell Physiol. 91, 335–344 (1976).
Nilsson, S. K., Johnston, H. M. & Coverdale, J. A. Blood 97, 2293–2299 (2001).
Calvi, L. M. et al. Nature 425, 841–846 (2003).
Kiel, M. J., Yilmaz, O. H., Iwashita, T., Terhorst, C. & Morrison, S. J. Cell 121, 1109–1121 (2005).
Cancelas, J. A. et al. Nature Med. 11, 886–891 (2005).
Lapidot, T. et al. Nature 367, 645–648 (1994).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Williams, D., Cancelas, J. Niche retreats for stem cells. Nature 444, 827–828 (2006). https://doi.org/10.1038/444827a
Published:
Issue Date:
DOI: https://doi.org/10.1038/444827a
- Springer Nature Limited
This article is cited by
-
Nanotechniques Inactivate Cancer Stem Cells
Nanoscale Research Letters (2017)
-
Altered mesenchymal niche cells impede generation of normal hematopoietic progenitor cells in leukemic bone marrow
Leukemia (2016)
-
CD44 standard and CD44v10 isoform expression on leukemia cells distinctly influences niche embedding of hematopoietic stem cells
Journal of Hematology & Oncology (2014)
-
New insights in cellular and molecular aspects of BM niche in chronic myelogenous leukemia
Tumor Biology (2014)
-
CD44: can a cancer-initiating cell profit from an abundantly expressed molecule?
Nature Reviews Cancer (2011)